utility

header_second

RegMed Investors (RMi) went exclusive on July 27th!

Your complimentary subscription to RegMed Investors’ (RMi) reporting on the stem, cell and gene therapy and RegMed sector has expired.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

It’s up to you to choose the level of content access to provide a premium experience and value - don’t wait to exhale!

I also bring fresh perspectives that yield a whole that is greater than the sum of the parts as I convey a spectrum of factors that explain outcomes, analytical principles and analysis without the encumbrance of trading, investment or I-Banking.

So, after these years of following our facts … first and fast; be part of our “inner circle” as a subscriber!

Stay with me and join our coalition and have a seat at the appreciation table!

Login Sign up now Not now

content_top

34 companies, 1 interpreter! Insight, foresight
and recommendation

Out and About

content_middle

content_right

June 12, 2023 - 11:16am | Out and About, Research Notes, Out and About
RegMed Investors (RMi) Research Note: Intellia Therapeutics (NTLA +$2.30 or +5.32% TO $45.54) pops on news of its CRISPR-based gene-editing drug almost completely eliminated attacks in a rare swelling disease

NTLA
May 27, 2023 - 12:37pm | Out and About, Research Notes, Out and About, Earnings Alert, Earnings, Earnings Q1
RegMed Investors (RMi) Research Note: Q1/23 earnings reporting dates, net losses, cash positions and runway outcomes

SGMO, SAGE, MDXG, AXGN
May 15, 2023 - 11:40am | Out and About, Research Notes, Out and About
UniQure NV (QURE) to sell royalty interest in blood disorder therapy for up to $400 M

QURE
April 10, 2023 - 4:40pm | Out and About, Research Notes, Out and About, Earnings, Earnings Q4
RegMed Investors (RMi) Research Note: Q4 and FY22 earnings reporting

SAGE, RARE, CRSP, EDIT, VCEL, NTLA, QURE, MESO, BEAM, VYGR, KDNY, FIXX, CRBU, AGEN, AXGN, VSTM, BLUE, ADVM, BCLI
March 17, 2023 - 8:48am | Out and About, Research Notes, Out and About
RegMed Investors (RMi) Research Note: Silicon Valley Bank Group (SIVB) files for bankruptcy

SIVB
March 13, 2023 - 11:28am | Out and About, Research Notes, Out and About
RegMed investors (RMi) Research Note: the aftermarket of catching a falling knife without a cut or slash

ADVM, BLFS, NTLA, RENE.L, RARE, CRSP, ALNY, QURE, BLUE, RGNX, EDIT, FATE, GBT, IONS, VCEL, KDNY, AXGN, SGMO, FIXX, MESO, SLDB
March 12, 2023 - 7:37pm | Out and About, Research Notes, Out and About
RegMed Investors (RMi) Research Note: protecting the cell and gene therapy sector depositors as FDIC laid out a back stop for the banking system

SVB
March 12, 2023 - 12:20pm | Out and About, Research Notes, Out and About
RegMed Investors: Special from Gleneagles, a luxury golf resort in Scotland, and spoke from a room framed by dark cabinets.

SVB
February 28, 2023 - 6:01pm | Out and About, Research Notes, Out and About, Earnings
RegMed Investors (RMi) Research Note: Upcoming Q4 earnings reporting dates

RARE, SAGE, IONS,ALNY, VCEL, FATE
February 8, 2023 - 7:39am | Out and About, Research Notes, Out and About, Financings
Cellectis SA (CLLS) closes 9.9 M ADS offering at $2.50

CLLS
January 25, 2023 - 10:55am | Out and About, Research Notes, Out and About, Financings
Precigen (PGEN) $75 M offering priced at $1.75

PGEN
January 24, 2023 - 8:07pm | Out and About, Research Notes, Out and About, Financings
Verastem Oncology (VSTM) $60 M Private Placement Offering of Series B Convertible Preferred Stock

VSTM
January 18, 2023 - 10:19am | Out and About, Research Notes, Out and About, Financings
bluebird bio (BLUE) prices offering of 20 M shares at $6.00

BLUE
January 9, 2023 - 1:49pm | Out and About, Research Notes, Out and About
RegMed Investors (RMi) Research Note: News related to JPM23

IONS, EDIT, VYGR, BLFS, MDXG, SLDB, AXGN, BEAM, ALNY, SAGE
January 2, 2023 - 2:18pm | Out and About, Research Notes, Out and About
RegMed investors (RMi) Research Note: Agenus (AGEN) possible offering of 1.95 million share

AGEN
December 1, 2022 - 6:56am | Out and About, Research Notes, Out and About, Financings
RegMed investors (RMi) Research Note: Intellia Therapeutics (NTLA) prices offering of 6.25 million shares priced at $45.80

Intellia Therapeutics (NTLA)
November 15, 2022 - 12:02pm | Out and About, Research Notes, Out and About
RegMed Investors (RMi) Research Note: Applied Genetic Technologies (AGTC)

Applied Genetic Technologies (AGTC)
November 10, 2022 - 9:42am | Out and About, Research Notes, Out and About
RegMed Investors (RMi) research note: BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) Shut-down by FDA on New Biologics License Application (BLA) for the ALS treatment with NurOwn

BrainStorm Cell Therapeutics (BCLI)
November 7, 2022 - 10:01am | Out and About, Research Notes, Out and About
Verve Therapeutics (VERV -$8.02 or -19.08% to $23.27) crashes after FDA halts IND to test gene editor Ion patients

Verve Therapeutics (VERV)
November 2, 2022 - 11:11am | Out and About, Research Notes, Out and About
Compass Therapeutics (CMPX) files for a private investment in public equity (PIPE) financing to raise $80 million

CMPX

Pages

footer

© 2015 RegMed Investors (regmedinvestors.com), all rights are reserved.

RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry MCusker . Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of RegMed Investors (RM-i); who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other RM-i media services or reposting please email hwm@regmedinvestors.com.